To start, the company just got FDA approval for a test that detects the deadly staph superbug – an illness that is reaching epidemic proportions in parts of the U.S.
And it doesn’t end there. Thermo Fisher and the broader lab equipment sector are tapped into a sea chance of sorts as 78 million baby boomers anticipate more doctor visits as they grow older.
That’s why the fastest money on the Street has put TMO under the microscope – and they like what they see.
Got something to to say? Send us an e-mail at firstname.lastname@example.org and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to email@example.com.
Trader disclosure: On Apr. 17, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders: Najarian Owns (AAPL), (BIIB), (CSCO), (ETFC), (NOK), (TSO), (XLF), (YHOO), (BSC) Calls, (CHK) Calls, (COP) Calls, (GOOG) Calls, (MSFT) Calls, (POT) Calls; Finerman’s Firm Is Short Pounds, (IYR), (IJR), (SPY), (IWM), (MDY), (COF), Owns (BJS), (MO), (MSFT), (NYX), (SUN), (TSO), (VLO), (YHOO); Finerman Owns (GS); Finerman’s Firm and Finerman Own (FLS); Macke Owns (MSFT), (DIS), (YHOO), (INTC)
Charles Schwab Is A Sponsor Of "Fast Money"
GE Is The Parent Company Of CNBC
NBC Universal Is The Parent Company Of CNBC